Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 14, 2019

Father’s Day and Our Fight Against Cancer

When Ryan Smith's father was diagnosed with cancer, the two of them decided to dedicate themselves to cancer. They committed that if they ever made any more money or had any influence, they would use the platform and money to fight cancer. And they have and will continue to do so with 5 For The Fight, which invites everybody to give $5 for the fight against cancer.

Jun 13, 2019

Grateful to Be a Dad: Celebrating the Opportunity to Have Children after Cancer Treatment

When I was diagnosed with multiple myeloma at the age of 26 it was by far the scariest thing I had ever faced. I had been married for about a year at the time I was diagnosed. At the time I was focused on staying alive, but the incredible team at HCI knew that if being a father was even remotely in the cards (which it was), we needed to take measures to ensure a future family was a possibility.

Jun 12, 2019

Determining Risk of Recurrence in Triple-Negative Breast Cancer

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.

Jun 06, 2019

Caring for Patients with a Family History of Pancreatic Cancer

Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas cancer screening strategies for certain patients with a family history of the disease.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.

May 31, 2019

Celebrating LGBTQ+ Pride at Huntsman Cancer Institute

In celebration of LGBTQ+ Pride month in June, Huntsman Cancer Institute (HCI) will illuminate the Beacon of Hope in rainbow colors this weekend, highlight LGBTQ+ staff and caregivers on social media, and participate in the Utah Pride Parade on Sunday, June 2.

May 30, 2019

Looking Ahead to New Discoveries during Cancer Research Month

Scientists at Huntsman Cancer Institute work hard every day to understand cancer from its beginnings and to use that knowledge in the creation and improvement of cancer treatments. To recognize National Cancer Research Month, we asked the leaders of our research programs what projects and goals they are focused on this year.